What We Do

Human judgment where it matters.
AI everywhere else.

Four service pillars — each combining the analytical power of PrimeHealth Prism with the strategic judgment of a seasoned healthcare finance operator.

01 — Revenue Cycle

Revenue Cycle
Optimization

Most healthcare organizations are leaving money on the table — not because they lack effort, but because they lack visibility. Prism surfaces exactly where revenue is leaking and what to do about it.

Prism Does
  • Denial pattern analysis by payer, code, and reason
  • A/R aging benchmarking vs. specialty peers
  • Net collection rate trending & gap analysis
  • Payer contract reimbursement benchmarking
  • KPI dashboard build & automated reporting
Advisor Adds
  • Payer renegotiation strategy & execution
  • Billing team performance recommendations
  • Pre-service collections protocol design
  • Appeals strategy for high-value denials
  • Board-level revenue cycle reporting
Lower denial rate
Faster cash collections
Better payer contracts
Board-ready KPIs
Prism — Revenue Cycle Snapshot
$297K
Revenue Recovery Identified
4.2%
Denial Rate (vs. 6.1% avg)
38d
A/R Days
92%
Net Collection Rate
Top Prism Finding: Authorization-related denials increased 18% YoY. Concentrated in 2 payers accounting for 84% of denial volume. Est. recovery opportunity: $142K addressable within 60 days.
✦ Prism Analysis
02 — Financial Planning

Financial Planning
& Analysis (FP&A)

You shouldn't be presenting to your board with data that's already a month old. Prism builds the models. Your advisor builds the narrative. Together, you walk into every meeting with clarity and confidence.

Prism Does
  • Annual budget build & variance tracking
  • Multi-year financial modeling & scenarios
  • Weekly cash flow forecasting
  • Monthly P&L performance reporting
  • Working capital & liquidity monitoring
Advisor Adds
  • Board & executive presentation preparation
  • Forecast narrative & strategic interpretation
  • Sensitivity analysis for key decisions
  • Investor/lender reporting support
  • Zero-based budgeting for new initiatives
Board-ready financials
Accurate forecasts
Cash visibility
Faster close cycles
Prism — FP&A Dashboard
+8.4%
Revenue vs. Budget
$2.1M
Cash on Hand
18.2%
EBITDA Margin
62d
Cash Runway
Prism Forecast: Q3 revenue projected at $4.8M — 6.2% above budget. Primary driver: improved payer mix shift. Cash position remains stable. Board presentation ready.
✦ Prism Analysis
03 — Strategic Advisory

Strategic Planning
& Growth Advisory

Growth decisions made without rigorous financial modeling are bets, not strategies. Prism builds the economics. Your advisor pressure-tests the assumptions. Every major move gets the analysis it deserves.

Prism Does
  • Service line expansion feasibility & pro-formas
  • De novo site financial modeling
  • M&A target financial analysis
  • Payer mix optimization modeling
  • Partnership & JV deal economics
Advisor Adds
  • Strategic framing for board & investors
  • Integration risk identification
  • Payer strategy & relationship leverage
  • Market entry timing recommendations
  • Capital structure guidance
Confident growth decisions
De novo pro-formas
M&A diligence
JV economics
Prism — Growth Scenario Model
$3.2M
Year 2 Revenue Projection
22mo
Break-Even Timeline
31%
Projected EBITDA Margin
4.1x
5-Year ROI
De Novo Analysis: New service line feasible under base-case assumptions. Breakeven achievable in month 22. Downside scenario still cash-flow positive by month 30. Recommendation: Proceed with staged capital deployment.
✦ Prism Analysis
04 — Cost Management

Cost Management
& Operational Finance

Margin improvement isn't about cutting blindly — it's about knowing exactly where your costs stand relative to peers and which levers move the needle. Prism gives you the data. Your advisor drives the negotiations.

Prism Does
  • Cost structure benchmarking vs. peer organizations
  • Labor cost & productivity analysis
  • Supply & vendor spend analytics
  • CAPEX planning & ROI modeling
  • Margin improvement opportunity sizing
Advisor Adds
  • Vendor contract negotiation strategy & execution
  • Staffing model redesign recommendations
  • Build vs. buy analysis for key functions
  • Specialty cost reduction roadmap
  • Margin improvement accountability tracking
Margin improvement
Better vendor terms
Cost benchmarking
CAPEX clarity
Prism — Cost Benchmarking Report
-14%
Cost vs. Peer Median
$88K
Supply Savings Identified
3
Vendor Renegotiation Targets
+4.1%
Margin Improvement Target
Prism Finding: Supply spend 18% above peer median in 2 categories. Anesthesia contract and implant pricing are primary drivers. Estimated savings: $88K annually through renegotiation.
✦ Prism Analysis

Ready to see Prism in action?

Start with a Financial Health Assessment — a one-time diagnostic across all four pillars. Most clients identify opportunities that pay for it within the first week.

Schedule a Discovery Session →